Mera Pharmaceuticals, Inc. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Mera Pharmaceuticals, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Mera Pharmaceuticals, Inc.. The Company's principal activities are to develop and commercialize natural products from microalgae using the large-scale photobioreactor technology known as Mera Growth Module (MGM). Its three operations are Natural Products,Contract services and Royalties. It uses its photobioreactor technology in the production and marketing of its first commercial product, ASTAFACTOR(R), a nutraceutical & source of natural astaxanthin. Its Trademarks & Service marks are SALMONESSENTIALS, AQUAXAN, MERA PHARMACEUTICALS, MERA GROWTH MODULE, MERA PROCESS CONTROL SYSTEM, MERA REMOTE DATA WEB ACCESS & DRUGS FROM THE SEA. The microalgae are known to contain valuable substances that have existing & potential commercial applications in fields such as animal and human nutrition, food colorings, cosmetics, diagnostic products, pharmaceuticals, research grade chemicals, pigments & dyes. It operates in the United States, Korea & Malaysia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report